Dwyer J, Coates P, Smith M
This article reports that discontinuation of semaglutide 2.4 mg is followed by weight regain, supporting the need for continued treatment to maintain weight loss
Last Updated: Dec 28, 2022 Written by Dr
Increased engagement Visually appealing image ads have a natural ability to grab users attention as they scroll through their feeds
availability has been significantly curtailed - No branded pharmaceutical product exists **Semaglutide:** - FDA-approved for weight management (Wegovy, 2.4 mg weekly) - FDA-approved for type 2 diabetes (Ozempic, up to 2.0 mg weekly) - Available through licensed pharmacies worldwide - Also available through 503B compounding pharmacies as a **weight loss peptide injection** - [View semaglutide products](/products/semaglutide-001) ### Injection Protocol Comparison **AOD-9604 typical research protocol:** - Dose: 250-300 mcg per injection - Frequency: Daily subcutaneous injection (fasting, typically morning) - Cycle length: 12-20 weeks - Total injections per month: ~30 **Semaglutide weight loss injection protocol:** - Starting dose: 0.25 mg weekly (4-week titration steps) - Maintenance dose: 2.4 mg weekly - Frequency: Once weekly subcutaneous injection - Total injections per month: 4 The convenience advantage is substantial
How This Compares to Brand-Name Alternatives For context, brand-name Wegovy or Zepbound through retail pharmacies typically costs $1,000 to $1,500 or more per month without insurance
